FY26 Preliminary Final Report
Filed with ASX · · 45 pages · English
1 A reconciliation between reported loss and underlying loss after tax is contained in the following operating and financial review of this Preliminary Final Report (Unaudited) for the year ended 30 June 2026. 2 Weighted average number of shares at 30 June 2026 determined to be 726.1 million for basic and diluted earnings per share calculations. Refer to Note A5 for further information on earnings
Earlier from Healius
- Healius transitions pathology arrangements with Ramsay
- FY26 trading update and strategic review of assets
- Healius announces 1H 2026 results
- Half Yearly Report and Accounts
- Half Year 2026 Results Presentation
Later from Healius
- FY26 Results Release
- FY26 Results Presentation
- S&P DJI Announces September 2026 Quarterly Rebalance
- Agreement to sell Agilex Biolabs to Novotech
Follow Healius into a list and get an email when it puts out news.
Follow Healius